Projects per year
Personal profile
Research interests
Tessel Rigter is an inquisitive researcher with a PhD in “Translating the dynamics of genetics into health care practice”, and experience in policy-informing studies. Skilled in translational research, qualitative study design, scientific writing, and teaching. Motivated by creating impact by building bridges, stimulating knowledge exchange, and defining strategies for optimization and change in the field of Public Health Genomics.
She is board member of the Dutch Association for Community Genetics and Public Health Genomics (NACGG).
She is program leader of the Personalized Medicine program from the Amsterdam Public Health (APH) research institute.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Research associate, Clinical genetics, Amsterdam UMC
1 Jan 2019 → 31 Jul 2020
Researcher, National Institute for Public Health and the Environment (RIVM), Netherlands
1 Sept 2014 → …
Collaborations and top research areas from the last five years
-
ERUDIGIT: Empowering citizens for responsible use of direct to consumer genetic testing
Rigter, T., Bruins, D., Cornel, M. & Damman, O.
1/11/2022 → 1/11/2026
Project: Research
-
-
-
Eurogentest2: Genetic Testing in Europe - Network for the further development, harmonization, validation and standardization of services
1/06/2011 → 1/06/2013
Project: Research
-
Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies
Onstwedder, S. M., Jansen, M. E., Leonardo Alves, T., Cornel, M. C. & Rigter, T., 24 May 2022, In: Frontiers in genetics. 13, 865799.Research output: Contribution to journal › Article › Academic › peer-review
Open Access4 Citations (Scopus) -
Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide: how innovation challenges screening criteria worldwide
Cornel, M. C., Rigter, T., Jansen, M. E. & Henneman, L., Apr 2021, In: Journal of community genetics. 12, 2, p. 257-265Research output: Contribution to journal › Article › Academic › peer-review
34 Citations (Scopus) -
Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
Rigter, T., Jansen, M. E., Groot, J. M. D., Janssen, S. W. J., Rodenburg, W. & Cornel, M. C., 31 Jan 2020, In: Frontiers in genetics. 11, 10.Research output: Contribution to journal › Article › Academic › peer-review
Open Access34 Citations (Scopus) -
Opportunistische farmacogenetische screening DNA-data gebruiken die al beschikbaar zijn
Jansen, M. E., Rigter, T. & de Wert, G. M. W. R., 1 Feb 2021, In: Nederlands Tijdschrift voor Geneeskunde. 165, 7, D5130.Translated title of the contribution :Opportunistic pharmacogenetic screening: Using available DNA-data Research output: Contribution to journal › Article › Professional
-
Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
Rigter, T., Klein, D., Weinreich, S. S. & Cornel, M. C., Oct 2021, In: European journal of human genetics. 29, 10, p. 1477-1484 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access9 Citations (Scopus)
Activities
- 2 Membership of board
-
Netherlands Assocation of Community Genetics and Public Health Genomics (NACGG) (External organisation)
Tessel Rigter (Member)
1 Jan 2022Activity: Membership › Membership of board › Academic
-
APH - Personalized Medicine (Organisational unit)
Tessel Rigter (Chair)
1 Dec 2021Activity: Membership › Membership of board › Academic
Press/Media
-
CRISPR Medicine News: How can society regulate and afford CRISPR therapies?
20/07/2021
1 Media contribution
Press/Media: Interview